Current Approach for Treating Anemia in LR-MDS

Opinion
Video

A medical oncologist outlines approaches to treating anemia in patients with lower-risk myelodysplastic syndromes.

Video content above is prompted by the following:

  • What is your current approach for treating anemia in LR-MDS?
    • When would you choose ESAs for first-line treatment?
      • When would you switch therapies? Would you dose escalate before switching to an EMA (e.g. second-line)?
    • What factors lead to a decision to use luspatercept as a first-line treatment?
      • When do you dose escalate?
Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content